Matt Angel

Dr. Angel is a pioneer in the field of mRNA therapeutics, and a prolific inventor, holding more than 80 patents covering mRNA, nucleic-acid delivery, gene-editing, and cell-reprogramming technologies.

Dr. Angel serves as President and is a co-founder of Factor Bioscience, a cell engineering technology development company in Cambridge, Massachusetts. Prior to co-founding Factor Bioscience, he was a member of MIT Lincoln Laboratory’s Biodefense Systems Group, where he developed technologies for the detection and mitigation of biological weapons threats.

Dr. Angel received his B.S. in engineering from Princeton University, and his PhD in electrical engineering from the Massachusetts Institute of Technology, where he studied the innate immune system and its response to exogenous mRNA.

In addition to serving as its CSO, he serves on the Board of Directors of Exacis.